Friedhelm R. Schuster

Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Optimizing Outcomes After Pediatric Haploidentical Donor Transplant: Role of Graft-Versus-Host Disease Prophylaxis?

Optimizing Outcomes After Pediatric Haploidentical Donor Transplant: Role of Graft-Versus-Host Disease Prophylaxis?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 21, 2026

Excellent survival after allogeneic HSCT in screened SCID patients and donor type dependent naïve T cell reconstitution.

Excellent survival after allogeneic HSCT in screened SCID patients and donor type dependent naïve T cell reconstitution.

Journal: Bone marrow transplantation

Published: February 17, 2026

Early Haploidentical Hematopoietic Stem Cell Transplantation Provides Rapid Leukocyte and Immune Reconstitution in AK2 Patient Identified by TREC Newborn Screening.

Early Haploidentical Hematopoietic Stem Cell Transplantation Provides Rapid Leukocyte and Immune Reconstitution in AK2 Patient Identified by TREC Newborn Screening.

Journal: Journal of clinical immunology

Published: August 15, 2024

Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCT.

Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCT.

Journal: Blood advances

Published: June 21, 2023

Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial.

Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 28, 2023

Automated production of specific T cells for treatment of refractory viral infections after allogeneic stem cell transplantation.

Automated production of specific T cells for treatment of refractory viral infections after allogeneic stem cell transplantation.

Journal: Haematologica

Published: August 25, 2022

Expression of Surface-associated 82 kDa proMMP-9 in Lymphatic Leukemia Blast Cells Differentially Correlates With Prognosis.

Expression of Surface-associated 82 kDa proMMP-9 in Lymphatic Leukemia Blast Cells Differentially Correlates With Prognosis.

Journal: Anticancer research

Published: May 27, 2021

Comments on the guidelines of the European Malignant Hyperthermia Group on the availability of dantrolene for the management of malignant hyperthermia crises

Comments on the guidelines of the European Malignant Hyperthermia Group on the availability of dantrolene for the management of malignant hyperthermia crises

Journal: Der Anaesthesist

Published: September 16, 2020

Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in 'DC-culture-media' shifts correlations of released chemokines with antileukemic T-cell reactions.

Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in 'DC-culture-media' shifts correlations of released chemokines with antileukemic T-cell reactions.

Journal: Immunobiology

Published: July 19, 2020

Expression profiles of HMGB1 on B-CLL related leukocytes contribute to prediction of relapse.

Expression profiles of HMGB1 on B-CLL related leukocytes contribute to prediction of relapse.

Journal: Immunobiology

Published: July 12, 2020

Caregiver involvement in psychiatric inpatient treatment - a representative survey among triads of patients, caregivers and hospital psychiatrists.

Caregiver involvement in psychiatric inpatient treatment - a representative survey among triads of patients, caregivers and hospital psychiatrists.

Journal: Epidemiology and psychiatric sciences

Published: May 23, 2020

Serum Chemokine-release Profiles in AML-patients Might Contribute to Predict the Clinical Course of the Disease.

Serum Chemokine-release Profiles in AML-patients Might Contribute to Predict the Clinical Course of the Disease.

Journal: Immunological investigations

Published: September 20, 2019

Showing 1-12 of 42

Last Updated: 09/26/2026